- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Feline BNP antibody and antigen (recombinant protein)
Diagnostic anti-Feline BNP antibodies pairs and antigen for animal health (animal Cat/Feline Cardiovascular Disease) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-FEL-BNP-Ag01 | Feline BNP | $3090.00 |
| GMP-FEL-BNP-Ab01 | Anti-Feline BNP mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-FEL-BNP-Ab02 | Anti-Feline BNP mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-FEL-BNP-Ab03 | Anti-Feline BNP human monoclonal antibody (mAb) | $3090.00 |
| GMP-FEL-BNP-Ab04 | Anti-Feline BNP human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-FEL-BNP-Ag01 |
| Product Name | Feline BNP |
| Target/Biomarker | Feline BNP |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Feline BNP antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in BNP level test of animal Cat/Feline with Cardiovascular Disease. |
| Tag | His | Reconized/Reactive Specics | Feline BNP |
| Product description | Recombinant Feline BNP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-FEL-BNP-Ab01,GMP-FEL-BNP-Ab02 |
| Target/Biomarker | Feline BNP |
| Product Name | Anti-Feline BNP mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Feline BNP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline BNP antibodies in Feline BNP level test of animal Cat/Feline with Cardiovascular Disease. |
| Product description | Anti-Feline BNP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline BNP antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-FEL-BNP-Ab03,GMP-FEL-BNP-Ab04 |
| Target/Biomarker | Feline BNP |
| Product Name | Anti-Feline BNP human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Feline BNP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Feline BNP antibodies in Feline BNP level test of animal Cat/Feline with Cardiovascular Disease. |
| Product description | Anti-Feline BNP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Feline B-type Natriuretic Peptide, commonly referred to as Feline BNP, assumes a central role in the intricate web of feline cardiovascular health. Synthesized predominantly within the ventricles of the heart in domestic cats (Felis catus), this peptide hormone is a key player in the regulation of blood pressure and fluid balance. It is part of the larger natriuretic peptide family, with atrial natriuretic peptide (ANP) as its companion, orchestrating the physiological symphony of cardiovascular stability.
The production and release of Feline BNP are finely tuned processes, responsive to the demands placed on the feline heart. When the heart encounters increased pressure or volume overload, often due to conditions like congestive heart failure (CHF), valvular disease, or cardiomyopathy, the ventricles react by liberating Feline BNP into the bloodstream. This response serves as a natural mechanism to alleviate the cardiac workload and maintain blood pressure within the ideal range.
The actions of Feline BNP are executed through its binding to specific receptors in the kidneys and blood vessels. This binding event initiates a cascade of events leading to increased excretion of sodium and water by the kidneys, promoting diuresis. This diuretic effect translates into a reduction in blood volume, a lightened burden on the heart, and the restoration of cardiovascular equilibrium.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
